Pharmaceutical

USPTO allows patents for Remedy’s large hemispheric infarction drug

The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating LHI.

Mar 21, 2025 - 06:00
USPTO allows patents for Remedy’s large hemispheric infarction drug
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating LHI.
Read the original article

Tags:

Previous Article

Allogeneic cell therapies “poised for prime time” says expert

Next Article

Sarepta’s Elevidys Under Scrutiny Following Fatal Liver Complication

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

STAT+: Backed by Mayo Clinic and Microsoft, a nonprofit...

Jan 8, 2024

Generate:Biomedicines and Novartis link on protein therapeutics development

Generate:Biomedicines and Novartis link on protein ther...

Sep 26, 2024

GSK’s Nucala for severe eosinophilic asthma gains approval in China

GSK’s Nucala for severe eosinophilic asthma gains appro...

Jan 11, 2024